Important safety information | Prescribing Information | Health Care Professionals | Send to a friend
Independence starts here, with NovoLog® Mix 70/30 FlexPen®

If you’re looking for a simple way to control your blood glucose, NovoLog Mix 70/30 can help. It’s one insulin that works in two different ways. It covers your mealtime glucose levels and covers between meals, too. And, most importantly, it’s an insulin that your doctor can adjust to your blood glucose needs as they change. By taking the time to learn more about NovoLog Mix 70/30 and NovoLog Mix® 70/30 FlexPen®, you can feel good knowing that you’re taking an important step towards independence with your diabetes treatment.

Click on the links below for more information:

Blood glucose control     Starting insulin treatment
Converting from another insulin     Weighing your options

Blood glucose control
To treat the ups and downs of blood glucose, many people take two types of insulin. One insulin that can last for up to 24 hours, and one that treats the spikes in glucose levels that happen when you eat. With NovoLog Mix 70/30, you can take one insulin to cover both of these.*

  • 70% has an extended action for in between meals and throughout the night
  • 30% acts fast for mealtime coverage

NovoLog Mix 70/30 offers control of your blood glucose when you need it. This means that while you take it, you won’t need any additional insulin. All you’ll need—is one insulin.

Back to top

Converting from another insulin
If you’re currently taking insulin, it’s important to know your options. Taking a long-acting insulin or oral medicine alone may not offer the mealtime coverage you need.4 And juggling two different types of insulin in your daily routine may be unnecessary. Not to mention costly, considering the additional copays.

Some people only need to take NovoLog Mix 70/30 once daily.9 It works for up to 24 hours, and covers mealtime glucose surges. And it works faster than human premixed insulin. You can eat within 15 minutes of taking it.*

  • NovoLog Mix 70/30 can help you reach your A1C goals, and it offers better mealtime coverage than human premixed insulin4,5
  • People who take NovoLog Mix 70/30 have experienced 73% fewer low blood glucose episodes than those taking human premixed insulin after 1 year6

Plus, NovoLog Mix 70/30 comes in NovoLog Mix 70/30 FlexPen, which is portable and easy to use. So it can help you have glucose control when you need it, wherever you need it.

Back to top

Starting insulin treatment
Diabetes is a disease that develops over time. And after a few years, many people who take diabetes pills eventually need to take insulin. NovoLog Mix 70/30 can be a good option. It’s one insulin you can continue taking over time. That’s because your doctor can adjust your dosage to fit your needs as they change. In a recent study, nearly half of people taking NovoLog Mix 70/30 just once daily reached their A1C goals. And for those taking NovoLog Mix 70/30 twice daily, 70% reached their goals.9

Plus, it’s available in NovoLog Mix 70/30 FlexPen, the preferred prefilled insulin pen.7,8 FlexPen® offers accurate dosing through an easy-to-use delivery system. It is prefilled and disposable, and can fit in your purse or pocket. So you can take FlexPen with you, wherever you go.

NovoLog Mix 70/30 FlexPen uses NovoFine® 30 needles, which are made ultra-thin to help make injecting more comfortable. In fact, NovoFine 30 needles were rated practically pain-free by 90% of people surveyed.§

Back to top

Weighing your options
As someone living with diabetes, you deserve a treatment that has a lot to offer. With the simplicity of taking just one insulin, and the convenience of FlexPen, NovoLog Mix 70/30 may be the right option for you.

Back to top

Ask your doctor about NovoLog Mix 70/30 today.

* Dosing of NovoLog Mix 70/30 will differ among patients and should be set by the health care professional familiar with the patient’s energy needs, eating habits, and other lifestyle factors. As with all insulins, the length of action may vary according to the dose, injection site, blood flow, temperature, and level of physical activity and conditioning.

The importance of differences in high postprandial (after-meal) glucose levels between the groups studied as it relates to long-term complications of diabetes has not been established.

§ Participants (people with type 1 and type 2 diabetes) in this survey (N=803) answered a detailed questionnaire after switching from a vial and syringe to the NovoPen® 1.5 for 3 weeks. The NovoPen 3 is a larger capacity version of the NovoPen 1.5.